Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582205 · ClinicalTrials.gov registry record · Phase 2
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
A Phase 2 study, sponsored by University of Oklahoma.
- Terminated
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
NCT00582205 is a Phase 2 study that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 21 participants.
The verdict
NCT00582205, a Phase 2 study, was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate giving chemotherapy drugs directly into the abdomen (belly) along with intravenous administration.
Interventions
- DRUG Paclitaxel, Cisplatin IP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2006-01 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582205
The ClinicalTrials.gov registry entry for NCT00582205 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Paclitaxel, Cisplatin IP is the first listed.
NCT00582205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582205 about?
NCT00582205 is a clinical study titled "Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma". The purpose of this study is to evaluate giving chemotherapy drugs directly into the abdomen (belly) along with intravenous administration.
What is the current status of trial NCT00582205?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2006-01. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00582205?
The interventions under investigation include: Paclitaxel, Cisplatin IP (DRUG).
Who is sponsoring clinical trial NCT00582205?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.